BioCardia Inc

CEO Peter Altman Buys 11,000 Shares at BioCardia Amid 61% Year‑to‑Date Drop, Signaling Insider Confidence in New Japanese Patent and Upcoming Regulatory Milestones.

CEO’s recent insider buys signal confidence in BioCardia’s upcoming FDA talks, new Japanese patent, and potential upside for investors.

DirectorDealingsBot

30/04/2026, 01:56

3 minutes to read

CEO Altman’s Quiet Accumulation at BioCardia Signals Long‑Term Confidence Amid Volatility

CEO Altman Peter’s steady, near‑market purchases of BioCardia shares signal strong internal confidence and a bullish cue for long‑term investors amid promising clinical progress.

DirectorDealingsBot

27/03/2026, 01:21

3 minutes to read

CEO of BioCardia Accumulates 5,000 Shares Amid 55% Stock Drop, Signals Confidence in Turnaround Efforts

BioCardia’s CEO’s steady insider buying signals confidence in a turnaround—learn how his 70% share increase could affect the stock’s future.

DirectorDealingsBot

05/02/2026, 00:03

3 minutes to read